Does anyone have experience with SLUPP as an injectable? We have a patient injecting a solution of 2ml bac water .5ml of DSMO and 5mg of the SLUPP powder. I am having a hard time finding it in the injectable form through our 503A pharmacy's. Is there a big difference between it and the pill form other than the obvious?

What s your experience with frozen shoulder in menopausal women? @Anthony Castore

Most people treat the brain like a furnace. When it runs cold, when the focus thins out and the afternoon turns to fog, the instinct is to shovel in more fuel. More coffee. More sugar. More of whatever promises a lift. The logic feels airtight. Low energy means add energy. But the brain is not really a furnace. It is closer to a house run by a thermostat, and most of the time the problem is not the size of the fire. It is the quality of the signal telling the system what to do. Hold onto that picture, because almost every mistake people make with brain energy comes from confusing the furnace with the thermostat. Start with the fuel, because that part is real. Your brain runs on two main substrates. The default is glucose, sugar pulled from the blood and burned for quick energy. Glucose is the loud, on-demand generator in the basement. It works, it is always running, and it is also a little dirty. Lean on it too hard for too long and the output gets noisy. The 3pm wall, the flat afternoons, the sense that you are revving the engine just to hold a steady line, a lot of that is a brain stuck running its loudest fuel with nothing quieter to switch to. There is a second line, and most people never bring it online. Ketones. The main one worth knowing is beta-hydroxybutyrate, which everyone shortens to BHB. Here is the part that gets misunderstood. BHB is a cleaner fuel, and that is true, but the cleaner burn is not the headline. The headline is that BHB barely behaves like fuel at all. It behaves like a message. When circulating BHB sits in roughly the half to two-and-a-half millimolar range, the kind of mild ketosis you reach through fasting, low-carb eating, or exogenous ketones, it does two things that have nothing to do with combustion. This is where the biology is genuinely well established, so I will say so plainly. First, BHB acts as an HDAC inhibitor. Unpack that. HDACs are little molecular hands that keep certain genes wound up tight and switched off. When BHB blocks them, those genes get to unspool and turn on. One of the genes that comes online is FOXO3, which you can think of as the foreman that calls up your antioxidant defense crew. So a molecule you assumed was just fuel walks into the nucleus and tells the cell to build its own protection. Second, BHB quiets the NLRP3 inflammasome. The inflammasome is the brain's smoke alarm, a sensor that, when it goes off, drives the kind of low, smoldering neuroinflammation that wears down neurons over time. BHB turns the sensitivity down. So the cleaner fuel arrives carrying two instructions at once. Protect yourself, and stop sounding the alarm. That is the furnace log that is also a hand on the thermostat.

The strange thing is how often the body looks most “stuck” right after someone has become most disciplined. They are training harder. They are eating cleaner. Steps are up. Alcohol is down. The scale should be moving. But instead there is this familiar cluster: the legs feel heavy before the warm-up is over, soreness lasts too long, sleep gets a little more fragile, resting heart rate drifts upward, joints start whispering, digestion gets touchy, and the body holds water like it knows something the spreadsheet does not. The usual interpretation is moral. They must be missing something. They must not be trying hard enough. They must need more deficit, more output, more pressure. But cells do not read fat loss plans. Cells read threat, energy, damage, repair, oxygen, nutrients, redox pressure, and timing. They are not trying to make someone lean. They are trying to survive long enough to adapt. That is where cGAS-STING becomes interesting. Not because it explains every fat loss stall. It does not. Biology is never that obedient. But it gives us a powerful way to understand how a cell can move from “this stress is useful” to “this stress is starting to look dangerous.” The pathway is usually written as cGAS-STING. cGAS stands for cyclic GMP-AMP synthase. STING stands for stimulator of interferon genes. The clean textbook version is simple: DNA is supposed to live in the nucleus and mitochondria. When DNA appears in the cytosol, the open working space of the cell, cGAS treats that as an alarm signal. It binds double-stranded DNA, makes a messenger called cGAMP, and cGAMP activates STING, which sits on the endoplasmic reticulum. STING then moves toward the ER-Golgi region, recruits TBK1, activates IRF3 and NF-κB signaling, and the cell begins producing type I interferons, inflammatory cytokines, and chemokines. That is the falling domino line. Misplaced DNA. cGAS. cGAMP. STING. TBK1. IRF3 and NF-κB. Interferon and inflammation. Immune recruitment. Tissue remodeling. Or, if it does not resolve, chronic defensive tone. But the more useful question is not “what does the pathway do?” The better question is: what problem is the cell trying to solve?

BPC keeps coming up in rooms where recovery actually matters. I recently had a fascinating conversation with Dr. Jermerly Girmann, a friend, mentor, and one of the most dialed-in regenerative medicine doctors I know. He has personally helped put me back together more than once, and his practice works with everyone from everyday injury cases to professional athletes across multiple sports. What made this conversation so interesting was what he has been seeing clinically with BPC in the context of post-surgical recovery, spine procedures, and complex orthopedic cases. We only scratched the surface, but it deserves a much deeper discussion. So we’re going to film a full conversation together and unpack the real-world clinical patterns, the nuance, and the questions that most people are not talking about publicly. That full interview will be released inside the paid tier of the community. This is the kind of conversation that moves beyond peptide hype and into what experienced clinicians are actually observing in practice. What caught my attention was that some of what he described seemed almost paradoxical compared to how BPC is usually talked about online. Most of the internet conversation sounds pretty simple. Tissue gets injured. Use BPC. Healing improves. In a lot of cases, that may be true. But, biology has a funny way of humbling you the second you start looking past the surface. The more we talked, the more I realized this wasn’t really a conversation about whether BPC is “good” or “bad.” That framing is too small. It was really a conversation about timing, terrain, and the physical space around the injury.Those three things can completely change how the same signal gets interpreted.That’s the part I keep coming back to. Cellular medicine is not really about protocols. Protocols can be useful, but they are not the intelligence. The intelligence is in the cell. The cell is constantly reading its environment and trying to decide what makes the most sense: defend, repair, reinforce, remodel, migrate, calm down, build blood vessels, lay collagen, or shut the process off.